Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $3.15 is 9.38% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 3.239||$ 5.35|
|Low:||$ 3.13||$ 2.88|
Company Description (as filed with the SEC)
Brainstorm Cell Therapeutics Inc. is a biotechnology company focused on the development and commercialization of innovative Central Nervous System ("CNS") adult stem cell therapies designed to address the significant unmet medical needs of patients with debilitating neurodegenerative diseases. Utilizing our proprietary mesenchymal stem cell platform technology, NurOwn®, Brainstorm is advancing therapies to treat a broad range of neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis ("ALS"), also known as Lou Gehrig's disease), Multiple Sclerosis ("MS"), and Parkinson's disease ("PD"), which currently have limited or no treatment options. 2017 and Recent Highlights · The Company made significant progress in 2017, advancing NurOwn®, our late stage differentiatedmesenchymal stem cell therapy, into a Phase 3 trial for the treatment of ALS. ... More ...
Nasdaq Official Price
Nov. 16, 2018
Nov. 16, 2018